Back

The role of intracoronary physiology measurements and acetylcholine provocation testing in patients with INOCA. First data from Latvia

25 April 2024 (14:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Poster session 2 - Assessing and managing cardiovascular risk in patients with acute cardiac syndromes and stroke Pathophysiology and Mechanisms Open Access ESC Preventive Cardiology 2024 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Barbara Vitola

Paul Stradins Clinical University Hospital, Riga (Latvia)

6 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor D. Maritsa (London, GB)
Abstract
Presentation thumbnail
Doctor X. Krasniqi (Pristina, XK)
Abstract Slides
Presentation thumbnail
Miss A. Tavaratsyan (Yerevan, AM)
Abstract Slides
Presentation thumbnail
Doctor R. Gregorio Antunes Coelho (Setubal, PT)
Abstract Slides

Access the full session

Session thumbnail
Poster session 2 - Assessing and managing cardiovascular risk in patients with acute cardiac syndromes and stroke

The Event

Event poster

ESC Preventive Cardiology 2024

25 April 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Characterization of different phenotypes of microvascular dysfunction and their impact on angina severity in patients with chronic angina without obstructive coronary artery disease: The MiVa Study
thumbnail
Congress Presentation
Effects of intracoronary nitrates administration on the invasive assessment of coronary microcirculation: insights from the INOCA NA registry
thumbnail
Congress Presentation
Critical coronary insights: low-threshold testing reduces coronary microvascular dysfunction (CMD) gender differences but CMD's 1-year impact persists

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources